- Home
- SOL vs ADAG Comparison
SOL vs ADAG Comparison
Compare SOL & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- ADAG
- Stock Information
- Founded
- SOL 2005
- ADAG 2011
- Country
- SOL United States
- ADAG China
- Employees
- SOL N/A
- ADAG N/A
- Industry
- SOL Semiconductors
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- SOL Technology
- ADAG Health Care
- Exchange
- SOL Nasdaq
- ADAG Nasdaq
- Market Cap
- SOL 94.9M
- ADAG 91.4M
- IPO Year
- SOL 2008
- ADAG 2021
- Fundamental
- Price
- SOL $1.91
- ADAG $1.88
- Analyst Decision
- SOL Strong Buy
- ADAG Strong Buy
- Analyst Count
- SOL 2
- ADAG 1
- Target Price
- SOL $4.50
- ADAG $8.00
- AVG Volume (30 Days)
- SOL 339.2K
- ADAG 92.2K
- Earning Date
- SOL 08-19-2025
- ADAG 07-24-2025
- Dividend Yield
- SOL N/A
- ADAG N/A
- EPS Growth
- SOL N/A
- ADAG N/A
- EPS
- SOL N/A
- ADAG N/A
- Revenue
- SOL $85,621,000.00
- ADAG $103,204.00
- Revenue This Year
- SOL N/A
- ADAG $6,488.89
- Revenue Next Year
- SOL $45.37
- ADAG $57.50
- P/E Ratio
- SOL N/A
- ADAG N/A
- Revenue Growth
- SOL N/A
- ADAG N/A
- 52 Week Low
- SOL $1.04
- ADAG $1.33
- 52 Week High
- SOL $3.00
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- SOL 62.80
- ADAG 44.87
- Support Level
- SOL $1.84
- ADAG $1.74
- Resistance Level
- SOL $1.91
- ADAG $2.10
- Average True Range (ATR)
- SOL 0.05
- ADAG 0.10
- MACD
- SOL -0.00
- ADAG -0.02
- Stochastic Oscillator
- SOL 95.65
- ADAG 16.67
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.